Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 357   Home Print this page  Email this page Small font size Default font size Increase font size
This article has been cited by
1Nuclear Imaging in Sarcoidosis
Eve Piekarski,Khadija Benali,François Rouzet
Seminars in Nuclear Medicine.2018;48(3)246
[DOI]
2Value of 18F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment
X. Palard-Novello,S. Querellou,M. Gouillou,A. Saraux,T. Marhadour,F. Garrigues,R. Abgral,P. Y. Salaün,V. Devauchelle-Pensec
European Journal of Nuclear Medicine and Molecular Imaging.2016;43(4)773
[DOI]
3Optimization of Pediatric PET/CT
Marguerite T. Parisi,Mohammed S. Bermo,Adam M. Alessio,Susan E. Sharp,Michael J. Gelfand,Barry L. Shulkin
Seminars in Nuclear Medicine.2017;47(3)258
[DOI]
4FDG-PET/CT Assessment of Pulmonary Sarcoidosis: A Guide for Internists
Marco Tana,Silvio di Carlo,Marcello Romano,Massimo Alessandri,Cosima Schiavone,Andrea Montagnani
Current Medical Imaging Formerly Current Medical Imaging Reviews.2018;15(1)21
[DOI]
5Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis
Mitsutomi Ishiyama,Laurie A. Soine,Hubert J. Vesselle
EJNMMI Research.2017;7(1)21
[DOI]
  Feedback 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal